08045804946
जांच भेजें
ODENSOMAB 60MG INJ
8000.0 आईएनआर/Number
उत्पाद विवरण:
X
मूल्य और मात्रा
- 1
व्यापार सूचना
- , ,
- प्रति सप्ताह
- दिन
- Yes
- , , , , , , , ,
उत्पाद वर्णन
Odensomab (denosumab) belongs to a class of medicines called RANK ligand inhibitors. It functions by binding to a protein called the RANK ligand (RANKL), which is essential for the formation, function, and survival of osteoclasts (cells that break down bone tissue). By inhibiting RANKL, the medication reduces bone resorption (breakdown), thereby increasing bone mineral density and making bones stronger and less likely to fracture.
Key Uses
The 60 mg strength of Odensomab injection is used to manage several conditions:
- Osteoporosis: Treatment of osteoporosis in postmenopausal women and men who are at high risk for fractures.
- Bone Loss: To increase bone mass in patients with bone loss due to reduced hormone levels caused by certain cancer treatments (e.g., androgen deprivation therapy for prostate cancer or aromatase inhibitor therapy for breast cancer).
- Giant Cell Tumor of the Bone (GCTB): To treat giant cell tumors of the bone by blocking specific receptors in the tumor cells, thus slowing their growth.
- Hypercalcemia: To treat high calcium levels in the blood caused by cancer when other treatments have failed.
Tell us about your requirement
Price: Â
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
मोबाइल number
Email
कैंसर रोधी औषधियाँ अन्य उत्पाद
संपर्क करें
- कार्यालय संख्या - 5, ग्राउंड फ्लोर, डी आर शॉपिंग सेंटर, दत्तपाड़ा रोड, एचडीएफसी बैंक के पास, बोरिवली पूर्व,मुंबई - 400066, महाराष्ट्र, भारत
- फ़ोन : 08045804946
- मर रणजीत सिंह (सीईओ व संस्थापक)
- मोबाइल : 08045804946
- medisus.pharma007@gmail.com
जांच भेजें
एसएमएस भेजेंMEDISUS PHARMA
सर्वाधिकार सुरक्षित.(उपयोग की शर्तें)
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
